Dr Susan Dimick

Dr Susan Dimick Clinical lipidologist at the central Oklahoma Early Detection Center. Edmond, Oklahoma.

The Tirzepatide Shortage Is Over – Now What? -
01/22/2025

The Tirzepatide Shortage Is Over – Now What? -

Late yesterday, FDA announced that Lilly’s tirzepatide shortage is officially over. Both Mounjaro and Zepbound are fully available in all marketed strengths and dosage forms.

Might Semaglutide Lower the Risk of Opioid Overdoses? -
01/20/2025

Might Semaglutide Lower the Risk of Opioid Overdoses? -

Caution is wise when observational studies compete for our attention. But this one, from JAMA Network Open,is intriguing. In a recent analysis of 33,006 persons with both type 2 diabetes and opioid use disorder, researchers found a signal that semaglutide might lower the risk of opioid overdoses by...

Just launched! Cholesterol Connect® Free Screening and Support Program to Address the Leading Cause of Death in America ...
01/17/2025

Just launched! Cholesterol Connect® Free Screening and Support Program to Address the Leading Cause of Death in America -

Family Heart Foundation®Launches “Cholesterol Connect®”, Free Screening and Personalized Support Program to Address the Leading Cause of Death in America

Press Release: Family Heart Foundation® Launches Cholesterol Connect® Free At-Home Screening and Personalized Support -
01/15/2025

Press Release: Family Heart Foundation® Launches Cholesterol Connect® Free At-Home Screening and Personalized Support -

New Program Provides Free At-Home Test Kits and Care Navigation Support to Improve Awareness and Manage Risks for Common Cardiovascular Disease Instigators, High Lipoprotein (a), Lp(a), and LDL-Cholesterol

The Rising Call to “Treat Obesity First” Starts to Resonate -
01/13/2025

The Rising Call to “Treat Obesity First” Starts to Resonate -

We are witnessing something rare. It is a sweeping change in how people are looking at a whole spectrum of chronic diseases. They all tie back to obesity: hypertension, high cholesterol, diabetes, many cancers, liver disease, kidney disease, and joint disease come quickly to mind. Most of the time,....

New Clothes, Better Food, Less Weight Watching, More Health -
01/10/2025

New Clothes, Better Food, Less Weight Watching, More Health -

Consumer spending is by far the biggest driver of U.S. economic growth. So you can be sure that businesses are paying close attention to the disruption in longstanding consumer behavior patterns that GLP-1 medicines are bringing. People are buying new clothes, better food, spending less on weight ...

ESC Congress: Everyone Now Claims the Disease of Obesity -
01/08/2025

ESC Congress: Everyone Now Claims the Disease of Obesity -

If nothing else, the ESC (European for Cardiology) Congress in London this week made one thing clear – everyone in mainstream medicine is now ready to claim the disease of obesity. Cardiologists all over the world are adopting a view we’ve been espousing here for decades. Obesity is not a life...

Statins Linked to Improved Liver Health in MASLD -
01/06/2025

Statins Linked to Improved Liver Health in MASLD -

Statin usage in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) is associated with a lower long-term risk for all-cause mortality, liver-related events, and progression of liver stiffness.

Tirzepatide Cuts Adverse Heart Failure Outcomes by 38% -
12/17/2024

Tirzepatide Cuts Adverse Heart Failure Outcomes by 38% -

One more chapter opened this week in the ongoing story of diseases that improve when healthcare providers effectively treat obesity. Lilly announced topline results from a study showing that tirzepatide cuts the rate of adverse heart failure outcomes in persons with obesity and heart failure by 38%....

A GLP-1, Liraglutide, Shows Potential to Slow Down Alzheimer’s -
12/10/2024

A GLP-1, Liraglutide, Shows Potential to Slow Down Alzheimer’s -

On the theme of “Is there anything GLP-1s can’t do?” a new randomized controlled trial is coming at us from the Alzheimer’s Association International Conference. It showed promising signs that a GLP-1, liraglutide, might slow the progression of Alzheimer’s disease.

Another Suggestion Semaglutide Might Cut Dementia Risk -
12/05/2024

Another Suggestion Semaglutide Might Cut Dementia Risk -

This latest hint was a surprise. It comes from research that aimed to measure the risk of neurological and psychiatric problems associated with taking semaglutide for type 2 diabetes. Riccardo De Giorgi and colleagues were concerned about reports of problems like depression and self harm following...

Address

105 S Bryant Avenue , Suite 304
Edmond, OK
73034

Opening Hours

Tuesday 9am - 5pm
Wednesday 9am - 8pm
Thursday 8am - 5pm
Friday 7:30am - 3:30pm
Saturday 9:30am - 5pm

Telephone

+14054750100

Alerts

Be the first to know and let us send you an email when Dr Susan Dimick posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category